Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2620 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AstraZeneca plc. (4/14/16). "Press Release: AstraZeneca Showcases Breadth of Oncology Portfolio at AACR 2016 Annual Meeting". 2016-04-14
Kymab Ltd.. (4/14/16). "Press Release: Kymab Appoints Leaders in Immuno-Oncology, Infectious Disease and Blood Disorders". Cambridge. 2016-04-14
Apollo Therapeutics Fund. (4/14/16). "Press Release: Dr Richard Butt Appointed CEO". Stevenage. 2016-04-14
Redx Pharma plc. (4/14/16). "Press Release: Redx Pharma plc Set for New HQ at Alderley Park". 2016-04-14
Redx Pharma plc. (4/14/16). "Press Release: Board and Senior Management Changes". 2016-04-14
Stevenage Bioscience Catalyst. (4/13/16). "Press Release: Sanofi Opens Partnering Office in Stevenage Bioscience Catalyst". Guildford. 2016-04-13
Cobra Biologics Ltd.. (4/13/16). "Press Release: Cobra and Lancaster Partnership Helps Unravel New Analytical Tool for DNA Topology". 2016-04-13
FIRE1 (Foundry Innovation & Research 1, Ltd.). (4/12/16). "Press Release: FIRE1 Closes Series B Financing, Announces New CEO". Dublin. 2016-04-12
Cosmo Pharmaceuticals S.A.. (4/7/16). "Press Release: Cosmo Board Approves Change of Registered Seat". Luxembourg. 2016-04-07
Edinburgh Molecular Imaging Ltd.. (4/7/16). "Press Release: Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration". Edinburgh & Paris. 2016-04-07
Adaptimmune Therapeutics plc. (4/7/16). "Press Release: Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford. 2016-04-07
BioSilta Ltd.. (4/6/16). "Press Release: BioSilta Ltd Acquires Worldwide Rights to CyDisCo Technology from University of Oulu to Produce Proteins with Multi-industry Applications". Cambridge. 2016-04-06
Markes International Ltd.. (4/5/16). "Press Release: New Paper in Analytical Chemistry – Select-eV Unravels the Composition of Complex Motor Oils". 2016-04-05
Dotmatics Ltd.. (4/5/16). "Press Release: Dotmatics Partners with BioByte to Offer ClogP Across the Entire Dotmatics Platform". Bishops Stortford & Claremont, CA. 2016-04-05
Proteome Sciences plc. (4/5/16). "Press Release: Deep Protein Profiling Key to Improving Cancer Treatment". Cobham. 2016-04-05
Oxford BioTherapeutics Ltd.. (4/4/16). "Press Release: Oxford BioTherapeutics Licenses Nerviano Medical Sciences’ Drug-Linker Technology to Develop Novel Antibody Drug Conjugates". Oxford & San Jose, CA & Nerviano. 2016-04-04
Fusion Antibodies Ltd.. (3/31/16). "Press Release: Fusion Antibodies and MAB Discovery Announce Project Collaboration". 2016-03-31
Adaptimmune Therapeutics plc. (3/30/16). "Press Release: U.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-03-30
Immunocore Ltd.. (3/30/16). "Press Release: Immunocore’s IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma". Oxford. 2016-03-30
Iterum Therapeutics Ltd.. (3/24/16). "Press Release: Iterum Therapeutics Licenses Global Rights to Novel Anti-Infective Compound. Secures $40 Million in Series A Funding". Dublin. 2016-03-24
Redx Pharma plc. (3/24/16). "Press Release: Placing to Raise £10 Million". 2016-03-24
Metrion Biosciences Ltd.. (3/21/16). "Press Release: Metrion Biosciences and EU Partners Receive €2.2M Funding Award under Eurostars SME Programme". Cambridge. 2016-03-21
Kymab Ltd.. (3/17/16). "Press Release: Kymab Appoints Dr David Chiswell as Chief Executive Officer". Cambridge. 2016-03-17
GlaxoSmithKline plc. (3/16/16). "Press Release: GSK and Miltenyi Biotec Establish Cell and Gene Therapy Collaboration". 2016-03-16
Microsaic Systems plc. (3/16/16). "Press Release: Audited Financial Results for the Year Ended 31 December 2015". 2016-03-16
Atlantic Healthcare plc. (3/15/16). "Press Release: Atlantic Healthcare Closes $24 Million Financing with Founders of Salix Pharmaceuticals and Clinigen Group, and LDC". Cambridge. 2016-03-15
Cambridge Epigenetix Ltd.. (3/14/16). "Press Release: Cambridge Epigenetix Announces $21M Series B Financing and Appoints Dr Geoff Smith as CEO". Cambridge. 2016-03-14
PhoreMost Ltd.. (3/10/16). "Press Release: PhoreMost and The Wistar Institute Collaborate to Identify New Druggable Targets in Cancer, Immunotherapy and Aging". Cambridge. 2016-03-10
PsiOxus Therapeutics Ltd.. (3/10/16). "Press Release: PsiOxus Therapeutics Initiates Combination of Paclitaxel with Oncolytic Virus Enadenotucirev in Ovarian Cancer Study". Oxford. 2016-03-10
Edinburgh Molecular Imaging Ltd.. (3/9/16). "Press Release: Edinburgh Molecular Imaging Ltd Awarded Innovate UK Grant to Qualify the Role of EMI-137 in Colorectal Cancer Lesion Detection". 2016-03-09
Grifols S.A.. (3/8/16). "Press Release: Industrial Investments Plan 2016–2021 for the Bioscience Division. Grifols Will Invest USD 360M to Expand Its Manufacturing Capacities for Plasma-derived Therapies". Barcelona. 2016-03-08
Capella Bioscience Ltd.. (3/8/16). "Press Release: Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline". London. 2016-03-08
Oxford BioMedica plc. (3/7/16). "Press Release: Oxford BioMedica Announces Expanded Collaboration and Licence with Immune Design". Oxford. 2016-03-07
Autolus Therapeutics Ltd.. (3/3/16). "Press Release: Autolus Limited Secures £40 Million Funding – Woodford Investment Management and Perceptive Bioscience Complete Series B Financing". London. 2016-03-03
Autolus Therapeutics Ltd.. (3/3/16). "Press Release: Autolus Limited Appoints Chief Executive Officer – Dr. Christian Itin, Pioneer of T-cell Targeting Therapeutics, Takes the Helm of Europe’s Leading Engineered T-cell Developer". London. 2016-03-03
Horizon Discovery Group plc. (3/2/16). "Press Release: Horizon Discovery Group plc Enters Immuno-Oncology Therapeutic Development and Forms Joint Venture with Centauri Therapeutics Limited". Cambridge. 2016-03-02
C4X Discovery Holdings plc. (3/1/16). "Press Release: Acquisition of Genetic Analysis Company. Adorial Limited Augments C4X Discovery’s Drug Discovery Engine". 2016-03-01
Oxford Immunotec Global plc. (3/1/16). "Press Release: Oxford Immunotec Reports Fourth Quarter and Full Year 2015 Financial Results". Oxford & Marlborough, MA. 2016-03-01
Quethera Ltd.. (3/1/16). "Press Release: The Welcome Trust [Grant]". 2016-03-01
Ziarco Pharma Ltd.. (2/29/16). "Press Release: Ziarco Appoints Dr. Arvind Hundal as Chief Business Officer". Discovery Park, Sandwich. 2016-02-29
Blue Scientific Ltd.. (2/25/16). "Press Release: Accurion Selects Blue Scientific as UK and Nordic Agent". 2016-02-25
Cobra Biologics Ltd.. (2/25/16). "Press Release: Cobra Biologics and Centre for Process Innovation Announce Collaboration to Advance Development of Regenerative Medicines". Keele & Cleveland. 2016-02-25
Oxford Nanopore Technologies Ltd.. (2/24/16). "Press Release: Response to Litigation". 2016-02-24
Microsaic Systems plc. (2/24/16). "Press Release: Update on Operations and Notice of Results". 2016-02-24
Oxford BioMedica plc. (2/23/16). "Press Release: Oxford BioMedica Announces a Proposed Placing to Raise £8.1 Million [not for United States, Australia, Canada, Japan or South Africa, et al.]". Oxford. 2016-02-23
Oxford Immunotec Global plc. (2/23/16). "Press Release: Oxford Immunotec to Present at the Cowen and Company 36th Annual Health Care Conference". Oxford & Marlborough, MA. 2016-02-23
Desktop Genetics Ltd.. (2/22/16). "Press Release: Desktop Genetics and Imperial College London Receive Innovate UK Grant Award for Site-Specific Epigenetic CRISPR Editing". London. 2016-02-22
Epistem Holdings plc. (2/19/16). "Press Release: Update on CEO Appointment". 2016-02-19
Peak Scientific Instruments Ltd.. (2/19/16). "Press Release: [Peak Protected] Supported Maintenance Brings Labs Increased Flexibility". 2016-02-19
Kymab Ltd.. (2/19/15). "Press Release: Kymab Appoints Anne Hyland as Chief Financial Officer". Cambridge. 2016-02-19
Akarna Therapeutics Ltd.. (2/16/16). "Press Release: Akarna Therapeutics Raises $15 Million Series B Financing to Develop Novel FXR Agonist-Based Therapies for the Treatment of NASH and other Fibrotic Diseases". San Diego, CA & Cambridge. 2016-02-16
Owlstone Inc.. (2/16/16). "Press Release: Owlstone Medical Wins NHS Contract for STRATA, Adapting Its Disease Breathalyzer technology for Precision Medicine and Companion diagnostics (CDx)". Cambridge. 2016-02-16
Consilium Strategic Communications Ltd.. (2/15/16). "Press Release: Consilium Strategic Communications Advises Shield Therapeutics plc on Its Successful £32.5m Fundraise and forthcoming IPO". London. 2016-02-15
Waters Corporation. (2/11/16). "Press Release: Waters and BioCity Debut New Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-02-11
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
Genomics England Ltd.. (2/11/16). "Press Release: Genomics England Enters Bioinformatics Partnership with Illumina". 2016-02-11
Mylan N.V.. (2/10/16). "Press Release: Mylan Full Year Adjusted Diluted EPS Up 21% to $4.30". Hertfordshire & Pittsburgh, PA. 2016-02-10
4D Pharma plc. (2/10/16). "Press Release: Acquisition [of Tucana Health Ltd.]". 2016-02-10
Adaptimmune Therapeutics plc. (2/9/16). "Press Release: U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma". Philadeliphia, PA & Oxford. 2016-02-09
Genomics England Ltd.. (2/9/16). "Press Release: Genomics England Selects Icon as Data Management Partner". 2016-02-09
Imperial Innovations Group plc. (2/4/16). "Press Release: Result of Placing [Not for United States, Australia, Canada or Japan or any other jurisdiction in which unlawful] ". 2016-02-04
Medicxi Ventures. (2/3/16). "Press Release: Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation". Castres. 2016-02-03
SBRI Healthcare. (2/3/16). "Press Release: £4.4 Million Awarded in Latest SBRI Healthcare Competition". 2016-02-03
EKF Diagnostics Holdings plc. (2/3/16). "Press Release: Trading Update". 2016-02-03
Adaptimmune Therapeutics plc. (2/3/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-02-03
AstraZeneca plc. (2/3/16). "Press Release: Tagrisso (osimertinib) Approved in EU as First-in-class Treatment for Patients with EGFR T790M Mutation-positive Metastatic Non-small Cell Lung Cancer". 2016-02-03
Adaptimmune Therapeutics plc. (2/2/16). "Press Release: Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration". London, Philadelphia, PA & Oxford. 2016-02-02
Cell and Gene Therapy Catapult, The. (2/2/16). "Press Release: Cell Therapy Catapult Is Now the Cell and Gene Therapy Catapult. New Name Reflects Mandate of the Catapult to Serve the Industry". London. 2016-02-02
Mission Therapeutics Ltd.. (2/2/16). "Press Release: Mission Therapeutics Raises £60 Million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform". Cambridge. 2016-02-02
Kymab Ltd.. (2/2/16). "Press Release: Kymab Succeeds in Revoking Regeneron’s UK VelocImmune Patents". Cambridge. 2016-02-02
Oxford Immunotec Global plc. (2/1/16). "Press Release: Patrick J. Balthrop, Sr., Former CEO of Luminex, Joins Oxford Immunotec Board of Directors". Oxford & Marlborough, MA. 2016-02-01
Francis Crick Institute Ltd., The. (2/1/16). "Press Release: HFEA Approval for New »Gene Editing« Techniques". 2016-02-01
Oxford BioMedica plc. (1/29/16). "Press Release: Oxford BioMedica Announces Initiation of Second CART Programme for Major Pharmaceutical Company". Oxford. 2016-01-29
Cancer Research UK. (1/27/16). "Press Release: CRT Announces License Agreement with MSD to Develop Inhibitors of PRMT5 for Cancer and Blood Disorders". 2016-01-27
Inivata Ltd.. (1/26/16). "Press Release: Inivata Completes £31.5 Million ($45M) Series A Fundraising Round". Cambridge. 2016-01-26
Immunocore Ltd.. (1/25/16). "Press Release: Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma". 2016-01-25
Apollo Therapeutics Fund. (1/25/16). "Press Release: Apollo Therapeutics. Consortium of World-Leading UK Universities and Global Pharmaceutical Companies Launch £40 Million Fund to Drive Therapeutic Innovation". London. 2016-01-25
Domainex Ltd.. (1/25/16). "Press Release: Domainex and Cresset Announce Drug Discovery Services Alliance". Cambridge. 2016-01-25
Abingworth LLP. (1/21/16). "Press Release: Abingworth Raises $105m for First Dedicated Clinical Co-Development Fund". 2016-01-21
Blue Scientific Ltd.. (1/15/16). "Press Release: Blue Scientific Now Exclusive Distributor for Ametek in Ireland". 2016-01-15
Microsaic Systems plc. (1/14/16). "Press Release: Grant of Share Options". 2016-01-14
Shire plc. (1/11/16). "Press Release: Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases". Dublin & Bannockburn, IL. 2016-01-11
Kymab Ltd.. (1/7/16). "Press Release: Kymab and MD Anderson Announce Strategic Partnership in Immuno-Oncology Research & Development". Cambridge & Houston, TX. 2016-01-07
Eurofins Scientific. (1/7/16). "Press Release: Eurofins Genomics and Weatherbys Ireland Join Forces to Genotype One Million Cattle". 2016-01-07
PsiOxus Therapeutics Ltd.. (1/7/16). "Press Release: PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board. Former President of GSK Oncology Adds Depth of Cancer R&D Leadership". Oxford. 2016-01-07
Illumina, Inc.. (1/7/16). "Press Release: Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT". San Diego, CA. 2016-01-07
Waters Corporation. (1/6/16). "Press Release: Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-01-06
Genomics plc. (1/4/16). "Press Release: Genomics and Vertex Collaborate to Identify Target Therapeutic Pathways". Oxford. 2016-01-04
Cellectis S.A.. (12/23/15). "Press Release: Cellectis Files First Clinical Trial Application for UCART19, an Allogeneic Gene Edited CAR T-Cell Product for Hematological Malignancies". New York. 2015-12-23
Bayer AG. (12/21/15). "Press Release: Bayer and CRISPR Therapeutics AG Join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases". Leverkusen & Basel. 2015-12-21
Microsaic Systems plc. (12/21/15). "Press Release: Directorate Changes". 2015-12-21
Oxford Immunotec Global plc. (12/18/15). "Press Release: Oxford Immunotec to Present at the 34th Annual J.P. Morgan Healthcare Conference". Oxford & Marlborough, MA. 2015-12-18
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Enhances Long-term Growth through Oncology Investment in Acerta Pharma". 2015-12-17
AstraZeneca plc. (12/17/15). "Press Release: AstraZeneca Completes Acquisition of ZS Pharma". 2015-12-17
Ergomed plc. (12/16/15). "Press Release: Ergomed plc Provides Update on Co-Development Partnerships". Guildford. 2015-12-16
Malin Corporation plc. (12/16/15). "Press Release: Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.". Dublin. 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca to Strengthen Therapy Area Franchise through Acquisition of Takeda’s Respiratory Business". 2015-12-16
AstraZeneca plc. (12/16/15). "Press Release: AstraZeneca Continues Strategic Investment in China to Accelerate Delivery of Innovative Biologics and Targeted Medicines". 2015-12-16
Genomics England Ltd.. (12/16/15). "Press Release: New NHS Centres Join 100,000 Genomes Project". 2015-12-16
AstraZeneca plc. (12/15/15). "Press Release: AstraZeneca Completes Agreement with Perrigo for Rights to Entocort in the US". 2015-12-15
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top